An investigation on behalf of investors in Zosano Pharma Corp (NASDAQ:ZSAN) shares over potential wrongdoing at Zosano Pharma was announced and NASDAQ:ZSAN stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 04/27/2016 -- An investigation for shareholders of Zosano Pharma Corp (NASDAQ:ZSAN) was announced over potential breaches of fiduciary duties by certain Zosano Pharma directors.
Investors who purchased shares of Zosano Pharma Corp (NASDAQ:ZSAN) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.
The investigation by a law firm concerns whether certain Zosano Pharma directors breached their fiduciary duties and caused damage to the company and its shareholders.
Fremont, CA based Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company that has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Zosano Pharma Corp went public in January 2015 and shares of Zosano Pharma Corp (NASDAQ:ZSAN) grew to as high as $11.67 per share in March 2015. Since then shares of Zosano Pharma Corp (NASDAQ:ZSAN) declined to as low as $1.95 per share on January 22, 2016.
On April 25, 2016, NASDAQ:ZSAN shares closed at $2.05 per share.
Those who purchased shares of Zosano Pharma Corp (NASDAQ:ZSAN) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com